Julie Park, Ph.D. - Publications

Affiliations: 
Stanford University, Palo Alto, CA 

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Akache B, Grimm D, Shen X, Fuess S, Yant SR, Glazer DS, Park J, Kay MA. A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 330-9. PMID 17235311 DOI: 10.1038/Sj.Mt.6300053  0.546
2005 Akache B, Glazer D, Park J, Kay MA. 1084. A Screen for Host Cellular Proteins That Interact with Adeno-Associated Virus Capsid Proteins Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.631  0.492
2005 Park J, Yant SR, Kay MA. 191. Identification of a Novel Functional Domain in the Sleeping Beauty Transposase: Towards Alleviating the Restriction of SB Overproduction Inhibition Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.194  0.533
2004 Yant SR, Park J, Huang Y, Mikkelsen JG, Kay MA. Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells. Molecular and Cellular Biology. 24: 9239-47. PMID 15456893 DOI: 10.1128/Mcb.24.20.9239-9247.2004  0.511
2004 Yant SR, Park J, Huang Y, Mikkelsen JG, Kay MA. 819. Hyperactive Transposase Mutants of the Sleeping Beauty Transposon Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.717  0.524
2004 Park J, Yant SR, Kay MA. 148. The altered binding properties of sleeping beauty transposase hyperactive mutants may explain their enhanced efficacy Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.072  0.51
Show low-probability matches.